Advertisement
Australia markets close in 1 hour 20 minutes

  • ALL ORDS

    7,989.40
    -30.00 (-0.37%)
     

  • ASX 200

    7,720.80
    -29.20 (-0.38%)
     

  • AUD/USD

    0.6599
    -0.0010 (-0.15%)
     

  • OIL

    79.24
    +0.12 (+0.15%)
     

  • GOLD

    2,349.70
    +6.70 (+0.29%)
     

  • Bitcoin AUD

    94,648.16
    +2,339.30 (+2.53%)
     

  • CMC Crypto 200

    1,286.50
    +26.30 (+2.09%)
     

  • AUD/EUR

    0.6116
    -0.0003 (-0.05%)
     

  • AUD/NZD

    1.0970
    -0.0009 (-0.09%)
     

  • NZX 50

    11,614.31
    -37.85 (-0.32%)
     

  • NASDAQ

    18,198.61
    +37.41 (+0.21%)
     

  • FTSE

    8,414.99
    -18.77 (-0.22%)
     

  • Dow Jones

    39,431.51
    -81.29 (-0.21%)
     

  • DAX

    18,742.22
    -30.58 (-0.16%)
     

  • Hang Seng

    19,089.83
    -25.23 (-0.13%)
     

  • NIKKEI 225

    38,279.85
    +100.39 (+0.26%)
     

Veradigm to Participate in TD Cowen Annual Health Care Conference

Business Wire
·1-min read

CHICAGO, February 28, 2024--(BUSINESS WIRE)--Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology products and solutions, today announced that Dr. Yin Ho, Veradigm interim Chief Executive Officer, and Lee Westerfield, interim Chief Financial Officer, will present at the TD Cowen Annual Health Care Conference on Monday, March 4, 2024, at 9:50 AM Eastern Time.

About Veradigm®

Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. For more information about how Veradigm is fulfilling its mission of Transforming Health, Insightfully, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, and YouTube.

ADVERTISEMENT

View source version on businesswire.com: https://www.businesswire.com/news/home/20240228989426/en/

Contacts

Investors:
Jenny Gelinas
312-506-1237
jenny.gelinas@veradigm.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@veradigm.com